Deployment of a Mobile Laboratory for the Control and Monitoring of High-Consequence Infectious Diseases: An Illustration With the Ebola Virus, the Biowarfare Agents, and the COVID-19

Authors

  • Omar Nyabi Université Catholique de Louvain (UCL)
  • Olga Vybornova Université Catholique de Louvain (UCL)
  • Jean-Luc Gala Université Catholique de Louvain (UCL)

DOI:

https://doi.org/10.33423/jsis.v16i3.4444

Keywords:

strategic innovation, sustainability, Biological Light Fieldable Laboratory for Emergencies (B-LiFE), biological threats, pandemic response, global health risks, deployment in remote locations, laboratory information management system (LIMS)

Abstract

The novel coronavirus (COVID-19) pandemic has caused societal issues, economic and political tensions worldwide. This shows, once more, that dissemination of correct information based on scientific evidence together with a quick and concerted action is the key to build a sound capability for the management of biological emergencies.

Here, we summarize the lessons learned from our preparedness and intervention during (i) our deployment during the 2014-2016 Ebola outbreak in West Africa; (ii) our large-scale exercises from Horizon 2020 Security program where the focus is on handling intentional dispersion of infectious agents; and (iii) our fight against COVID-19: by the deployment of Biological Light Fieldable Laboratory for Emergencies (BLiFE mobile laboratory) in Turin and Novara, Piedmont Region, Italy.

At the latter deployment, the ultimate goal was a large screening for COVID-19 prevalence in primo intervention individuals. It cannot be ignored that the COVID-19 pandemic is an ideal situation to whet our preparedness, coordination of response and risks monitoring in case of future biological threats or attacks.

Downloads

Published

2021-08-12

How to Cite

Nyabi, O., Vybornova, O., & Gala, J.-L. (2021). Deployment of a Mobile Laboratory for the Control and Monitoring of High-Consequence Infectious Diseases: An Illustration With the Ebola Virus, the Biowarfare Agents, and the COVID-19. Journal of Strategic Innovation and Sustainability, 16(3). https://doi.org/10.33423/jsis.v16i3.4444

Issue

Section

Articles